The suppression of PPAR-γ genomic activity, by MAPK-mediated phosphorylation, is in concordance with the antiproliferative, antiinflammatory and prodifferentiating role of PPAR-γ and is supported by several in vitro studies, conducted in normal as well as in cancer cells. This evidence concerns the gene PPARG and cancer.